Cargando…

Dementia and disadvantage in the USA and England: population-based comparative study

OBJECTIVES: To compare dementia prevalence and how it varies by socioeconomic status (SES) across the USA and England. DESIGN: Population-based comparative study. SETTING: Non-Hispanic whites aged over 70 population in the USA and England. PARTICIPANTS: Data from the Health and Retirement Study and...

Descripción completa

Detalles Bibliográficos
Autores principales: Arapakis, Karolos, Brunner, Eric, French, Eric, McCauley, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496387/
https://www.ncbi.nlm.nih.gov/pubmed/34615672
http://dx.doi.org/10.1136/bmjopen-2020-045186
_version_ 1784579747022372864
author Arapakis, Karolos
Brunner, Eric
French, Eric
McCauley, Jeremy
author_facet Arapakis, Karolos
Brunner, Eric
French, Eric
McCauley, Jeremy
author_sort Arapakis, Karolos
collection PubMed
description OBJECTIVES: To compare dementia prevalence and how it varies by socioeconomic status (SES) across the USA and England. DESIGN: Population-based comparative study. SETTING: Non-Hispanic whites aged over 70 population in the USA and England. PARTICIPANTS: Data from the Health and Retirement Study and the English Longitudinal Study of Ageing, which are harmonised, nationally representative panel studies. The sample includes 5330 and 3147 individuals in the USA and England, respectively. MAIN OUTCOME MEASURES: Between country differences in age-gender standardised dementia prevalence, across the SES gradient. Dementia prevalence was estimated in each country using an algorithm based on an identical battery of demographic, cognitive and functional measures. RESULTS: Dementia prevalence is higher among the disadvantaged in both countries, with the USA being more unequal according to four measures of SES. Overall prevalence was lower in England at 9.7% (95% CI 8.9% to 10.6%) than the USA at 11.2% (95% CI 10.6% to 11.8%), a difference of 1.4 percentage points (pp) (p=0.0055). Most of the between country difference is driven by the bottom of the SES distribution. In the lowest income decile individuals in the USA had 7.3 pp (p<0.0001) higher prevalence than in England. Once past health factors and education were controlled for, most of the within country inequalities disappeared; however, the cross-country difference in prevalence for those in lowest income decile remained disproportionately high. CONCLUSIONS: There is inequality in dementia prevalence according to income, wealth and education in both the USA and England. England has lower dementia prevalence and a less steep SES gradient. Most of the cross-country difference is concentrated in the lowest SES group, which provides evidence that disadvantage in the USA is a disproportionately high risk factor for dementia.
format Online
Article
Text
id pubmed-8496387
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84963872021-10-22 Dementia and disadvantage in the USA and England: population-based comparative study Arapakis, Karolos Brunner, Eric French, Eric McCauley, Jeremy BMJ Open Public Health OBJECTIVES: To compare dementia prevalence and how it varies by socioeconomic status (SES) across the USA and England. DESIGN: Population-based comparative study. SETTING: Non-Hispanic whites aged over 70 population in the USA and England. PARTICIPANTS: Data from the Health and Retirement Study and the English Longitudinal Study of Ageing, which are harmonised, nationally representative panel studies. The sample includes 5330 and 3147 individuals in the USA and England, respectively. MAIN OUTCOME MEASURES: Between country differences in age-gender standardised dementia prevalence, across the SES gradient. Dementia prevalence was estimated in each country using an algorithm based on an identical battery of demographic, cognitive and functional measures. RESULTS: Dementia prevalence is higher among the disadvantaged in both countries, with the USA being more unequal according to four measures of SES. Overall prevalence was lower in England at 9.7% (95% CI 8.9% to 10.6%) than the USA at 11.2% (95% CI 10.6% to 11.8%), a difference of 1.4 percentage points (pp) (p=0.0055). Most of the between country difference is driven by the bottom of the SES distribution. In the lowest income decile individuals in the USA had 7.3 pp (p<0.0001) higher prevalence than in England. Once past health factors and education were controlled for, most of the within country inequalities disappeared; however, the cross-country difference in prevalence for those in lowest income decile remained disproportionately high. CONCLUSIONS: There is inequality in dementia prevalence according to income, wealth and education in both the USA and England. England has lower dementia prevalence and a less steep SES gradient. Most of the cross-country difference is concentrated in the lowest SES group, which provides evidence that disadvantage in the USA is a disproportionately high risk factor for dementia. BMJ Publishing Group 2021-10-05 /pmc/articles/PMC8496387/ /pubmed/34615672 http://dx.doi.org/10.1136/bmjopen-2020-045186 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Public Health
Arapakis, Karolos
Brunner, Eric
French, Eric
McCauley, Jeremy
Dementia and disadvantage in the USA and England: population-based comparative study
title Dementia and disadvantage in the USA and England: population-based comparative study
title_full Dementia and disadvantage in the USA and England: population-based comparative study
title_fullStr Dementia and disadvantage in the USA and England: population-based comparative study
title_full_unstemmed Dementia and disadvantage in the USA and England: population-based comparative study
title_short Dementia and disadvantage in the USA and England: population-based comparative study
title_sort dementia and disadvantage in the usa and england: population-based comparative study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496387/
https://www.ncbi.nlm.nih.gov/pubmed/34615672
http://dx.doi.org/10.1136/bmjopen-2020-045186
work_keys_str_mv AT arapakiskarolos dementiaanddisadvantageintheusaandenglandpopulationbasedcomparativestudy
AT brunnereric dementiaanddisadvantageintheusaandenglandpopulationbasedcomparativestudy
AT frencheric dementiaanddisadvantageintheusaandenglandpopulationbasedcomparativestudy
AT mccauleyjeremy dementiaanddisadvantageintheusaandenglandpopulationbasedcomparativestudy